{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:50:51Z","timestamp":1791917451600,"version":"4.3.4"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The pediatric obesity disease burden imposes the necessity of new effective strategies.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether oral butyrate supplementation as an adjunct to standard care is effective in the treatment of pediatric obesity.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A randomized, quadruple-blind, placebo-controlled trial was performed from November 1, 2020, to December 31, 2021, at the Tertiary Center for Pediatric Nutrition, Department of Translational Medical Science, University of Naples Federico II, Naples, Italy. Participants included children aged 5 to 17 years with body mass index (BMI) greater than the 95th percentile.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Standard care for pediatric obesity supplemented with oral sodium butyrate, 20 mg\/kg body weight per day, or placebo for 6 months was administered.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcome was the decrease of at least 0.25 BMI SD scores at 6 months. The secondary outcomes were changes in waist circumference; fasting glucose, insulin, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride, ghrelin, microRNA-221, and interleukin-6 levels; homeostatic model assessment of insulin resistance (HOMA-IR); dietary and lifestyle habits; and gut microbiome structure. Intention-to-treat analysis was conducted.<\/jats:p><\/jats:sec>Results<\/jats:title>Fifty-four children with obesity (31 girls [57%], mean [SD] age, 11 [2.91] years) were randomized into the butyrate and placebo groups; 4 were lost to follow-up after receiving the intervention in the butyrate group and 2 in the placebo group. At intention-to-treat analysis (n\u2009=\u200954), children treated with butyrate had a higher rate of BMI decrease greater than or equal to 0.25 SD scores at 6 months (96% vs 56%, absolute benefit increase, 40%; 95% CI, 21% to 61%; P<\/jats:italic>\u2009&amp;lt;\u2009.01). At per-protocol analysis (n\u2009=\u200948), the butyrate group showed the following changes as compared with the placebo group: waist circumference, \u22125.07 cm (95% CI, \u22127.68 to \u22122.46 cm; P<\/jats:italic>\u2009&amp;lt;\u2009.001); insulin level, \u22125.41 \u03bcU\/mL (95% CI, \u221210.49 to \u22120.34 \u03bcU\/mL; P<\/jats:italic>\u2009=\u2009.03); HOMA-IR, \u22121.14 (95% CI, \u22122.13 to \u22120.15; P<\/jats:italic>\u2009=\u2009.02); ghrelin level, \u221247.89 \u03bcg\/mL (95% CI, \u221291.80 to \u22123.98 \u03bcg\/mL; P<\/jats:italic>\u2009&amp;lt;\u2009.001); microRNA221 relative expression, \u22122.17 (95% CI, \u22123.35 to \u22120.99; P<\/jats:italic>\u2009&amp;lt;\u2009.001); and IL-6 level, \u22124.81 pg\/mL (95% CI, \u22127.74 to \u22121.88 pg\/mL; P<\/jats:italic>\u2009&amp;lt;\u2009.001). Similar patterns of adherence to standard care were observed in the 2 groups. Baseline gut microbiome signatures predictable of the therapeutic response were identified. Adverse effects included transient mild nausea and headache reported by 2 patients during the first month of butyrate intervention.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Oral butyrate supplementation may be effective in the treatment of pediatric obesity.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT04620057<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.44912","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:03:08Z","timestamp":1670256188000},"page":"e2244912","source":"Crossref","is-referenced-by-count":113,"title":["Therapeutic Effects of Butyrate on Pediatric Obesity"],"prefix":"10.1001","volume":"5","author":[{"given":"Serena","family":"Coppola","sequence":"first","affiliation":[{"name":"Department of Translational Medical Science, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"ImmunoNutritionLab, CEINGE-Advanced Biotechnologies, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nocerino","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"ImmunoNutritionLab, CEINGE-Advanced Biotechnologies, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorella","family":"Paparo","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"ImmunoNutritionLab, CEINGE-Advanced Biotechnologies, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bedogni","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy"},{"name":"Department of Primary Health Care, Internal Medicine Unit Addressed to Frailty and Aging, S Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Di Scala","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"ImmunoNutritionLab, CEINGE-Advanced Biotechnologies, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Fiorenza","family":"de Giovanni di Santa Severina","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"ImmunoNutritionLab, CEINGE-Advanced Biotechnologies, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Filippis","sequence":"additional","affiliation":[{"name":"Task Force on Microbiome Studies, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"Department of Agricultural Sciences, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Ercolini","sequence":"additional","affiliation":[{"name":"Task Force on Microbiome Studies, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"Department of Agricultural Sciences, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Berni Canani","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"ImmunoNutritionLab, CEINGE-Advanced Biotechnologies, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"Task Force on Microbiome Studies, University of Naples \u201cFederico II,\u201d Naples, Italy"},{"name":"European Laboratory for the Investigation of Food-Induced Diseases, University of Naples \u201cFederico II,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"22","key":"zoi221270r2","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1056\/NEJMoa1703860","article-title":"Simulation of growth trajectories of childhood obesity into adulthood.","volume":"377","author":"Ward","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi221270r3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis.","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"zoi221270r4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity.","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"zoi221270r5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease.","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"zoi221270r6","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome.","volume":"65","author":"De Filippis","year":"2016","journal-title":"Gut"},{"issue":"10","key":"zoi221270r7","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/nu10101499","article-title":"Impact of diet-modulated butyrate production on intestinal barrier function and inflammation.","volume":"10","author":"Bach Knudsen","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"zoi221270r8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/molecules26030682","article-title":"The protective role of butyrate against obesity and obesity-related diseases.","volume":"26","author":"Coppola","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"zoi221270r9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5114\/pg.2020.95556","article-title":"Determination of butyric acid dosage based on clinical and experimental studies\u2014a literature review.","volume":"15","author":"Banasiewicz","year":"2020","journal-title":"Prz Gastroenterol"},{"issue":"2","key":"zoi221270r10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3325\/cmj.2009.50.105","article-title":"7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials.","volume":"50","author":"Krleza-Jeric","year":"2009","journal-title":"Croat Med J"},{"issue":"1","key":"zoi221270r12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13052-018-0525-6","article-title":"Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics.","volume":"44","author":"Valerio","year":"2018","journal-title":"Ital J Pediatr"},{"issue":"2","key":"zoi221270r13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0197-2456(00)00134-3","article-title":"Calculating confidence intervals for the number needed to treat.","volume":"22","author":"Bender","year":"2001","journal-title":"Control Clin Trials"},{"key":"zoi221270r14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00038-009-5408-6","article-title":"Overweight in school-aged children and its relationship with demographic and lifestyle factors: results from the WHO-Collaborative Health Behaviour in School-aged Children (HBSC) study.","volume":"54","author":"Haug","year":"2009","journal-title":"Int J Public Health"},{"issue":"1","key":"zoi221270r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054319","article-title":"High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers.","volume":"8","author":"Milagro","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"zoi221270r16","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00125-013-2950-9","article-title":"Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-a.","volume":"56","author":"Meerson","year":"2013","journal-title":"Diabetologia"},{"issue":"6","key":"zoi221270r17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/bioinformatics\/btr026","article-title":"Quality control and preprocessing of metagenomic datasets.","volume":"27","author":"Schmieder","year":"2011","journal-title":"Bioinformatics"},{"key":"zoi221270r18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65088","article-title":"Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3.","volume":"10","author":"Beghini","year":"2021","journal-title":"Elife"},{"issue":"11","key":"zoi221270r19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41592-018-0176-y","article-title":"Species-level functional profiling of metagenomes and metatranscriptomes.","volume":"15","author":"Franzosa","year":"2018","journal-title":"Nat Methods"},{"issue":"10","key":"zoi221270r20","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/bioinformatics\/btv033","article-title":"MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph.","volume":"31","author":"Li","year":"2015","journal-title":"Bioinformatics"},{"issue":"8","key":"zoi221270r21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s13238-010-0093-z","article-title":"Human gut microbiome: the second genome of human body.","volume":"1","author":"Zhu","year":"2010","journal-title":"Protein Cell"},{"issue":"4","key":"zoi221270r22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2.","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"7","key":"zoi221270r23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq.","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat Methods"},{"issue":"1","key":"zoi221270r24","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1038\/s41467-021-26266-z","article-title":"Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance.","volume":"12","author":"De Filippis","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"zoi221270r25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2014.05.014","article-title":"Diet, metabolites, and \u201cWestern-lifestyle\u201d inflammatory diseases.","volume":"40","author":"Thorburn","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"zoi221270r26","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/nu12051474","article-title":"The Firmicutes\/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"zoi221270r27","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.2337\/db14-1938","article-title":"GPR43 potentiates \u00df-cell function in obesity.","volume":"64","author":"McNelis","year":"2015","journal-title":"Diabetes"},{"issue":"12","key":"zoi221270r28","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/1535370217708188","article-title":"Butyrate reduces high-fat diet\u2013induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.","volume":"242","author":"Matheus","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"issue":"7","key":"zoi221270r29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068626","article-title":"Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.","volume":"8","author":"Mattace Raso","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"zoi221270r30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41424-018-0025-4","article-title":"Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.","volume":"9","author":"Bouter","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"zoi221270r31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1055\/s-0043-119089","article-title":"Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial.","volume":"49","author":"Roshanravan","year":"2017","journal-title":"Horm Metab Res"},{"issue":"3","key":"zoi221270r32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1079\/BJN20041225","article-title":"Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats.","volume":"92","author":"Cani","year":"2004","journal-title":"Br J Nutr"},{"issue":"3","key":"zoi221270r33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s42000-019-00100-0","article-title":"From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?","volume":"18","author":"Barrea","year":"2019","journal-title":"Hormones (Athens)"},{"issue":"7","key":"zoi221270r34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/gutjnl-2017-314050","article-title":"Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit.","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"issue":"1","key":"zoi221270r35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.domaniend.2011.04.001","article-title":"Plasma ghrelin concentration is decreased by short chain fatty acids in wethers.","volume":"41","author":"Fukumori","year":"2011","journal-title":"Domest Anim Endocrinol"},{"key":"zoi221270r36","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0012","article-title":"Obesity associated disease risk: the role of inherent differences and location of adipose depots.","author":"Hill","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"3","key":"zoi221270r37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on Visceral Obesity.","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"zoi221270r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154011","article-title":"LSD1 mediates microbial metabolite butyrate-induced thermogenesis in brown and white adipose tissue.","volume":"102","author":"Wang","year":"2020","journal-title":"Metabolism"},{"issue":"50","key":"zoi221270r39","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.1021\/acs.jafc.7b04666","article-title":"Structure-specific effects of short-chain fatty acids on plasma cholesterol concentration in male Syrian hamsters.","volume":"65","author":"Zhao","year":"2017","journal-title":"J Agric Food Chem"},{"issue":"5","key":"zoi221270r40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrendo.2015.25","article-title":"MicroRNA regulatory networks in human adipose tissue and obesity.","volume":"11","author":"Arner","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"zoi221270r41","doi-asserted-by":"publisher","first-page":"E1467","DOI":"10.1210\/jc.2015-2357","article-title":"Surgery-induced weight loss is associated with the downregulation of genes targeted by microRNAs in adipose tissue.","volume":"100","author":"Ortega","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"zoi221270r42","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1002\/jcb.26589","article-title":"miR-221 negatively regulates inflammation and insulin sensitivity in white adipose tissue by repression of sirtuin-1 (SIRT1).","volume":"119","author":"Peng","year":"2018","journal-title":"J Cell Biochem"},{"issue":"11","key":"zoi221270r43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","article-title":"The major inflammatory mediator interleukin-6 and obesity.","volume":"58","author":"Eder","year":"2009","journal-title":"Inflamm Res"},{"issue":"5","key":"zoi221270r44","doi-asserted-by":"publisher","first-page":"879","DOI":"10.7863\/ultra.16.04020","article-title":"Low-intensity ultrasound enhances histone acetylation and inhibition of interleukin 6 messenger RNA expression by the histone deacetylase inhibitor sodium butyrate in fibroblasts.","volume":"36","author":"Maeshige","year":"2017","journal-title":"J Ultrasound Med"},{"issue":"1","key":"zoi221270r45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000495203","article-title":"Butyrate modulates inflammation in chondrocytes via GPR43 receptor.","volume":"51","author":"Pirozzi","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"zoi221270r1","unstructured":"World Health Organization. Obesity and overweight. Accessed November 27, 2020. https:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/"},{"key":"zoi221270r11","unstructured":"World Health Organization. Child growth standards. Accessed October 28, 2022. https:\/\/www.who.int\/tools\/child-growth-standards\/standards"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799197\/coppola_2022_oi_221270_1743603011.29425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T15:50:02Z","timestamp":1744127402000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799197"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44912","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]}}}